Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Sacral nerve stimulation Stories

2010-09-28 06:47:00

Spinal Cord and Peripheral Nerve Stimulation Relieve Patient "Drug Fog" NEW YORK, Sept. 28 /PRNewswire-USNewswire/ -- Afflicting countless people worldwide, chronic pain is a largely misunderstood and under-treated disease that forever alters the lives of more than 50 million Americans each year. Many patients endure inadequate treatments and are forced to rely on prescription pain-killers that do little if anything to alleviate their symptoms and often lead to addiction. According to...

2010-09-23 08:27:00

MINNEAPOLIS, Sept. 23 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF...

2010-05-27 14:00:00

MINNEAPOLIS, May 27 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that at the May 28-June 2, 2010 Annual Meeting of the American Urological Association (AUA) in San Francisco, CA, there will be two presentations on Uroplasty's Urgent® PC Neuromodulation System and one on its...

2010-04-08 05:30:00

MINNEAPOLIS, April 8 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products to treat voiding dysfunctions, today announced that Monday, April 12, the company's Urgent® PC Neuromodulation System is expected to be featured in a segment of the popular television program "The Doctors." The Urgent PC System is a proprietary, minimally invasive, percutaneous tibial nerve...

2010-03-23 05:00:00

MINNEAPOLIS, March 23 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is a nonsurgical system for treatment of urinary urgency, urinary...

2010-03-02 05:30:00

MINNEAPOLIS, March 2 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that at the February 23-27, 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), in St. Petersburg, FL, nine presentations were made on Uroplasty's Urgent® PC Neuromodulation System and...

2010-03-01 05:30:00

MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of the SUmiT Trial of its Urgent® PC Neuromodulation System that will be published in the April 2010 print edition of THE JOURNAL OF UROLOGY® and is now available on line. The Urgent PC system is a proprietary, minimally...

2009-12-10 05:00:00

MINNEAPOLIS, Dec. 10 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®. The Urgent PC System is a proprietary, minimally invasive,...

2009-11-17 05:00:00

MINNEAPOLIS, Nov. 17 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations...

2009-09-03 05:30:00

MINNEAPOLIS, Sept. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System. The Urgent PC System is a proprietary, minimally invasive percutaneous tibial nerve stimulation (PTNS) device designed for office-based treatment of...